Package 57237-043-90

{"route": ["ORAL"], "spl_id": "84ee45f0-f89e-4873-88b2-259684b0bbf3", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313564", "313565"], "spl_set_id": ["8d1645c0-fd03-4992-9372-98026a26b3af"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (57237-043-05)", "package_ndc": "57237-043-05", "marketing_start_date": "20100524"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (57237-043-30)", "package_ndc": "57237-043-30", "marketing_start_date": "20100524"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (57237-043-90)", "package_ndc": "57237-043-90", "marketing_start_date": "20100524"}], "brand_name": "Valacyclovir Hydrochloride", "product_id": "57237-043_84ee45f0-f89e-4873-88b2-259684b0bbf3", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "57237-043", "generic_name": "Valacyclovir Hydrochloride", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir Hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1 g/1"}], "application_number": "ANDA090682", "marketing_category": "ANDA", "marketing_start_date": "20100524", "listing_expiration_date": "20261231"}